Oral Presentations inflammatory disease, HER2, hormone receptors, tumor grade, previous adjuvant chemotherapy, and prior anthracyclines. CON-CLUSIONS: Early lymphocyte recovery is an independent outcome predictor after HDC in MBC pts receiving a graft with a high T-cell content. These observations support the role for the immune system in tumor control after transplant, and suggest that pre-or post-HDC inmmne strategies targeting post-transplant residual disease may prove worthwhile. MBC pts

more »

... ian DFS Median OS % DFS % OS Low ALC (_<500/mm 3) 1 yr 2.5 yrs 20% 29% High ALC (>500/ram 3 ) 2.3 yrs 4 yrs 33% 42% STEM CELL BIOLOGY 31 BONE MARROW DERIVED HESENCHYMAL STEH CELLS : IMPACT ON NEOINTESTINAL ENGINEERING Gm~dia, C.; Defavia, W.; Smztiago, S.; Tryopl, o~mpoulos, P.; Ruiz, P.; Tzakis, A.; Kleiner, G.